Literature DB >> 7733709

Tricuspid valve regurgitation attributable to endomyocardial biopsies and rejection in heart transplantation.

B Hausen1, J M Albes, R Rohde, S Demertzis, A Mügge, H J Schäfers.   

Abstract

In the present report the prevalence, severity, and risk factors of tricuspid valve regurgitation (TR) in 251 heart transplant recipients have been analyzed retrospectively. Tricuspid valve function was studied by color-flow Doppler echocardiogram and annual heart catheterization. The presence or severity of TR was graded on a scale from 0 (no TR) to 4 (severe). Additional postoperative data included rate of rejection, number of endomyocardial biopsies, incidence of transplant vasculopathy, and preoperative and postoperative hemodynamics. The incidence of grade 3 TR increases from 5% at 1 year to 50% at 4 years after transplantation. Multivariate analysis showed rate of rejection and donor heart weight to be significant risk factors. The ischemic intervals as well as the preoperative and postoperative pulmonary hemodynamics did not affect the severity or prevalence of TR. These results indicate that various factors appear to have an impact on the development of TR and that the prevalence might be lowered by a reduction of the number of biopsies performed and when possible, oversizing of donor hearts.

Entities:  

Mesh:

Year:  1995        PMID: 7733709     DOI: 10.1016/0003-4975(95)00089-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Evidence-based surgical management of acquired tricuspid valve disease.

Authors:  Sung Ho Shinn; Hartzell V Schaff
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

2.  Tricuspid valve replacement after cardiac transplantation.

Authors:  S Ichikawa; Y Takeuchi; Y Suda; T Ban; S Nunoda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-10

3.  Modified inferior vena caval anastomosis to reduce tricuspid valve regurgitation after heart transplantation.

Authors:  Daniel Marelli; Scott C Silvestry; Donna Zwas; Paul Mather; Sharon Rubin; Anthony F Dempsey; Louis Stein; Evelio Rodriguez; James T Diehl; Arthur M Feldman
Journal:  Tex Heart Inst J       Date:  2007

4.  Epidemiological Study of Tricuspid Regurgitation After Cardiac Transplantation. Does it Influence Survival?

Authors:  Raquel López-Vilella; María J Paniagua-Martín; Francisco González-Vílchez; Víctor Donoso Trenado; Eduardo Barge-Caballero; Ignacio Sánchez-Lázaro; Ana V Aller Fernández; Luis Martínez-Dolz; María G Crespo-Leiro; Luis Almenar-Bonet
Journal:  Transpl Int       Date:  2022-03-21       Impact factor: 3.782

5.  Functional tricuspid valve insufficiency after cardiac transplantation: Which factor is the most important?

Authors:  Vüsal Hajiyev; Michael Dandel; Ruhi Yeter; Felix Schoenrath; Felix Hennig; Volkmar Falk; Christoph Knosalla
Journal:  JTCVS Open       Date:  2020-08-03

6.  Tricuspid valve regurgitation after orthotopic heart transplantation: prevalence and etiology.

Authors:  Yaniv Berger; Yedael Har Zahav; Yigal Kassif; Alexander Kogan; Rafael Kuperstein; Dov Freimark; Jacob Lavee
Journal:  J Transplant       Date:  2012-10-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.